Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
McKesson
Boehringer Ingelheim
Express Scripts
McKinsey

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

CYSTAGON Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Cystagon, and what generic alternatives are available?

Cystagon is a drug marketed by Mylan and is included in one NDA.

The generic ingredient in CYSTAGON is cysteamine bitartrate. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cysteamine bitartrate profile page.

Drug patent expirations by year for CYSTAGON
Recent Clinical Trials for CYSTAGON

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NHS GrampianPhase 1/Phase 2
University of HuddersfieldPhase 1/Phase 2
Cystic Fibrosis TrustPhase 1/Phase 2

See all CYSTAGON clinical trials

Pharmacology for CYSTAGON
Synonyms for CYSTAGON
.beta.-Aminoethanethiol
.beta.-Aminoethylthiol
.beta.-MEA
.beta.-Mercaptoethylamine
(2-Mercaptoethyl)amine
(Mercaptoethyl)ammonium toluene-p-sulphonate
1-Amino-2-mercaptoethylamine
106791-EP2292597A1
106791-EP2295407A1
106791-EP2298736A1
139720-70-0
156-57-0 (hydrochloride)
16904-32-8 (di-hydrochloride)
2-Amino-1-ethanethiol
2-AMINO-ETHANETHIOL
2-amino-ethyl thiol
2-aminoethane-1-thiol
2-aminoethanethio
2-Aminoethanethiol
2-Aminoethanethiol, 95%
2-Aminoethyl mercaptan
2-Mercaptoethanamine
2-Mercaptoethylamine
2-Mercaptoethylamine, polymer-bound
2-Mercaptoethylamine, polymer-bound, 70-90 mesh, extent of labeling: 0.6-1.1 mmol/g loading, 1 % cross-linked with divinylbenzene
2,3-DESHYDROLANTHIONINE
213515-EP2371809A1
27761-19-9 (tartrate (1:1))
2DFDA1F8-7010-4225-8280-AB1C4C43F546
3037-04-5 (tosylate)
42954-15-4 (hydrobromide)
5UX2SD1KE2
60-23-1
60-23-1 (Parent)
93965-19-6 (maleate (1:1))
A0648
AB00053754_09
AB00053754_10
AB0020070
AC1L1LPL
AC1Q54NL
ACMC-1AVBC
AKOS003793343
Aminoethyl mercaptan
AN-41805
ANW-33452
b-Aminoethanethiol
b-Aminoethylthiol
b-Mercaptoethylamine
BCP15015
BDBM7968
Becaptan
beta-Aminoethanethiol
beta-Aminoethylthiol
beta-MEA
beta-Mercaptoethylamine
bmse000388
BP-13401
C-9500
C01678
C2H7NS
CAS-60-23-1
CASH
CCG-204834
CCRIS 3083
CHEBI:17141
CHEMBL602
Cisteamina
Cisteamina [Italian]
CS-2799
CTK3J0325
Cystagone
Cystaran
Cystavision
Cysteamide
Cysteamin
CYSTEAMINE
Cysteamine (USAN)
Cysteamine [USAN:BAN]
Cysteamine [USAN]
Cysteamine bitartate
Cysteamine, >=98.0% (RT)
Cysteamine, ~95%
Cysteamine, free base
cysteaminium
Cysteinamine
D03634
DB-053562
DB00847
Decarboxycysteine
DHL
DivK1c_006750
DSSTox_CID_2875
DSSTox_GSID_22875
DSSTox_RID_76770
DTXSID3022875
EINECS 200-463-0
EINECS 221-235-7
Ethanethiol, 2-amino-
Ethanethiolamine
F0001-1576
FT-0611243
GTPL7440
HSDB 7353
HY-77591A
KB-20296
KBio1_001694
KBio2_002235
KBio2_004803
KBio2_007371
KBioSS_002235
KS-00000WES
KSC490G2L
L 1573
L-1573
Lambraten
Lambratene
Lopac-M-6500
LS-65761
MCULE-1838427828
MEA (mercaptan)
Mecramine
Mercamin
Mercamine
Mercaptamin
Mercaptamina
Mercaptamina [INN-Spanish]
Mercaptamine
Mercaptamine (INN)
Mercaptamine [INN]
Mercaptaminum
Mercaptaminum [INN-Latin]
mercapto ethylamine
Mercaptoethylamine
Merkamin
MolPort-001-662-635
NCGC00015691-01
NCGC00015691-02
NCGC00015691-03
NCGC00015691-04
NCGC00162236-01
NCGC00162236-02
NCI60_002000
NE18622
NSC 647528
NSC-647528
NSC647528
Riacon
RP18367
RTR-031658
SBI-0050727.P003
SC-18413
SpecPlus_000654
Spectrum_001755
STK315355
Thioethanolamine
Tox21_113092
TR-031658
UFULAYFCSOUIOV-UHFFFAOYSA-N
UNII-5UX2SD1KE2
V0810
WR 347
ZINC8034121

US Patents and Regulatory Information for CYSTAGON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan CYSTAGON cysteamine bitartrate CAPSULE;ORAL 020392-001 Aug 15, 1994 RX Yes No   Request a Trial   Request a Trial   Request a Trial
Mylan CYSTAGON cysteamine bitartrate CAPSULE;ORAL 020392-002 Aug 15, 1994 RX Yes Yes   Request a Trial   Request a Trial   Request a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Harvard Business School
Moodys
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.